GATESHEAD HEALTH NHS FOUNDATION TRUST

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Subsidiary

Established: 2005-01-01

Employees: -

Market Cap: -

Website: http://www.qehkl.nhs.uk/news-story.asp?id=681&s=news&ss=articles&p=news.story

Clinical Trials

Vascular Augmentation of Late-life Unremitted Depression (VALUeD)

Phase 3

Conditions: Depression

Interventions: Drug: Placebo
Drug: Amlodipine

First Posted Date: 2012-03-19

Last Posted Date: 2012-03-19

Lead Sponsor: Gateshead Health NHS Foundation Trust

Target Recruit Count: 80

Registration Number: NCT01557153

Locations: 🇬🇧
Clinical Ageing Research Unit, Newcastle upon Tyne, United Kingdom

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy